CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
about
Fatty acid metabolism and the basis of brown adipose tissue functionMitochondrial fatty acid oxidation in obesityNovel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cellsUCP4 overexpression improves fatty acid oxidation and insulin sensitivity in L6 myocytesAssociation of the CPT1B gene with skeletal muscle fat infiltration in Afro-Caribbean men.Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosisLipid-induced mitochondrial stress and insulin action in muscleCarnitine Palmitoyltransferase 1 Increases Lipolysis, UCP1 Protein Expression and Mitochondrial Activity in Brown Adipocytes.Malonyl-CoA mediates leptin hypothalamic control of feeding independent of inhibition of CPT-1aDietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay miceIntramuscular lipid oxidation and obesity.Metabolic reserve of the heart: the forgotten link between contraction and coronary flow.Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to ExerciseIntramuscular lipid metabolism, insulin action, and obesity.Mitofusion-2-mediated alleviation of insulin resistance in rats through reduction in lipid intermediate accumulation in skeletal muscle.The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance.Sex-specific alterations in mRNA level of key lipid metabolism enzymes in skeletal muscle of overweight and obese subjects following endurance exercise.The role of skeletal muscle sphingolipids in the development of insulin resistanceCarnitine and type 2 diabetes.Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus.Amelioration of palmitate-induced metabolic dysfunction in L6 muscle cells expressing low levels of receptor-interacting protein 140.Palmitate-induced skeletal muscle insulin resistance does not require NF-κB activation.Integrated analysis of chronic lipotoxicity on muscle metabolism and stress and its reversal by antioxidants.Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.Peroxisomal Acyl-CoA Oxidase Type 1: Anti-Inflammatory and Anti-Aging Properties with a Special Emphasis on Studies with LPS and Argan Oil as a Model Transposable to Aging.CPT1C promotes human mesenchymal stem cells survival under glucose deprivation through the modulation of autophagy.
P2860
Q26744147-8E09B75A-B3F3-42BC-9C7F-77B9AE9E53CEQ26820838-D075E609-9FE8-4FBA-BA6F-213EC97F7A04Q28574936-1D73984F-28CE-48EB-A1F8-F03BB5CB47FCQ28576358-F547EF16-1DFF-49DE-8970-581E8BB793D9Q33955024-DC9D645C-EC96-4296-9C5C-8E61CFD86A6BQ34031701-F4D464D2-7B87-4F01-9D66-A4A6D0122898Q34035340-02975811-A821-4C13-BD7C-0BCCC2ABE684Q34299225-BAF0E0AF-89FC-41D9-B65F-22CAB8CC3CC6Q35947486-D4E45B8C-5F3D-4F0E-8467-282DF28D0855Q36082820-22408E15-DCB9-47C6-822F-9055664182E1Q36563951-81764C3E-CE0D-4A1A-A7BB-686CBE1E48E4Q36604200-FCA71191-7D87-4D13-ADDF-0E0077CC1B5BQ36632211-D9203553-99D6-4FB9-95FB-82E3B9646690Q36821021-6A936F5D-D4A7-4077-8489-34F8EF51010BQ37012238-C945F786-A41D-45AD-9A2B-02AD823E44C9Q37034193-227D06B0-DD62-4367-AC74-D7665E071138Q37037985-4CDF853E-6470-4028-A9A3-BD41F9342132Q37061247-518206DF-0D2A-4831-8426-31723C86AE4BQ37105295-36CE0648-07C6-4F58-9863-8D5436C29EBAQ37106381-7A125729-A858-4D11-A958-20E2F0CE4994Q37189363-F1C03AEF-7383-4923-8F70-6D2EA70AA8ABQ37575094-9E4BE627-776A-4158-97A1-188C8BC25991Q37845219-D453BB5F-DDB9-454E-B2FA-36C11E3DBAFAQ37978926-65B82B16-D607-4ACD-A3A6-766F14F21937Q38832553-EA919054-DDFB-4587-B763-610D2A65587BQ39658915-9212E357-94C9-4A22-BF40-1E56DBE5C20EQ40403293-DF9D2AB6-3CEE-42CA-9AE2-A799E4E17837Q48055039-53E9EC89-003A-4BB4-8E2A-4CD9B81F359BQ54986126-80EF2A80-005B-4F3D-B6F8-C76E43F8C278Q55317169-93DB8194-F068-4121-870D-3FCBB1F7CACF
P2860
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
CPT I overexpression protects ...... id-induced insulin resistance.
@en
type
label
CPT I overexpression protects ...... id-induced insulin resistance.
@en
prefLabel
CPT I overexpression protects ...... id-induced insulin resistance.
@en
P2093
P921
P1476
CPT I overexpression protects ...... id-induced insulin resistance.
@en
P2093
David Sebastián
Fausto G Hegardt
Guillermina Asins
P304
P356
10.1152/AJPENDO.00360.2006
P577
2006-10-24T00:00:00Z